Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
INFINIUM Stock Analysis
Views
Red Flags
Positive
Not enough talking point with positive stance
Negative
Expensive and at a premium to industry median P/E
Company's earnings are of low quality
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0729619.
Snapshot
See detailed analysis
INFINIUM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
INFINIUM Bulk, Block & Insider Trades
INFINIUM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Bonus
Bonus(1 new shares for 1 existing shares) Ex-date: 13th Sep 2023 Announced on: 2nd Aug 2023
Company Profile
Infinium Pharmachem Limited is an India-based company. The Company is engaged in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. Its portfolio includes approximately 200+ Iodin... Read More
Key personnel
Mr. Sanjaykumar Viththalbhai PatelD
Executive Chairman of the Board, Managing Director
Mr. Nilesh Patel
Chief Financial Officer, Compliance Officer, Company Secretary
Mr. Mitesh Lavjibhai ChikhaliyaD
Executive Director
Mr. Pravin Bhadabhai MadhaniD
Executive Director
Mr. Tarun Ratilal DobariyaD
Non-Executive Independent Director
Mr. Keyur Jagdishchandra ShahD
Non-Executive Independent Director
Ms. Vaishakhi Ambrishbhai ShuklaD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Infinium Pharmachem Ltd.?
The current share price of Infinium Pharmachem Ltd. is ₹ 224.50 as of 09 Jan 2026.
What is the PE ratio of Infinium Pharmachem Ltd.?
The Price-to-Earnings (PE) ratio of Infinium Pharmachem Ltd. is 38.36 as of the latest financial data.
What is the ROE and ROCE of Infinium Pharmachem Ltd.?
Infinium Pharmachem Ltd. has a Return on Equity (ROE) of 9.68% and a Return on Capital Employed (ROCE) of 10.58% as per the latest financial reports.
What is the market cap of Infinium Pharmachem Ltd.?
The market capitalization of Infinium Pharmachem Ltd. stands at ₹ 312.41 Cr.
What is the dividend yield of Infinium Pharmachem Ltd.?
The dividend yield of Infinium Pharmachem Ltd. is 0.00% based on the current market price.
What is the RSI of Infinium Pharmachem Ltd.?
The Relative Strength Index (RSI) of Infinium Pharmachem Ltd. is 47.47.
What is the FII and DII holding in Infinium Pharmachem Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Infinium Pharmachem Ltd. shares.
What sector does Infinium Pharmachem Ltd. belong to?
Infinium Pharmachem Ltd. operates in the Healthcare sector.
What is the beta of Infinium Pharmachem Ltd. stock?
The beta of Infinium Pharmachem Ltd. stock is 1.17, indicating its volatility relative to the broader market.
